News

PolyPid Welcomes New Chief Medical Officer, Dr. Tweezer-Zaks

PolyPid Welcomes New Chief Medical Officer, Dr. Tweezer-Zaks

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

PolyPid Ltd. (NASDAQ: PYPD), a biopharmaceutical company dedicated to enhancing surgical outcomes, has recently announced a significant leadership change. Dr. Nurit Tweezer-Zaks has been appointed as the Chief Medical Officer, taking on this role as the company gears up for important regulatory submissions and product advancements. Dr. Tweezer-Zaks has been an invaluable member of PolyPid's Board of Directors since November 2023, and her transition into this executive position marks an exciting development for the firm.

"We are thrilled to welcome Dr. Tweezer-Zaks to our executive team at such a critical juncture for PolyPid, especially following our successful Phase 3 SHIELD II trial results," stated Dikla Czaczkes Akselbrad, PolyPid's CEO. With her comprehensive medical background and expertise in the industry, Dr. Tweezer-Zaks is well-prepared to drive the medical strategy forward during this transformative period. Her proven track record and insightful understanding of our technology will be essential as we approach our New Drug Application (NDA) submission and work to expand our pipeline.

Dr. Tweezer-Zaks' Expertise and Experience

Before joining PolyPid, Dr. Tweezer-Zaks served as the Chief Executive Officer of MediCane Health Inc., a global player in the medical cannabis sector. Her fascinating journey includes roles at aMOON Venture Capital Fund, where she held the position of Chief Medical Officer, contributing significantly to venture capital investments in life sciences. Furthermore, her time at Sanofi involved overseeing life cycle management for portfolio products and fostering external innovation, showcasing her exceptional range of expertise.

Dr. Tweezer-Zaks initiated her career as an internal medicine and rheumatology physician at the renowned Sheba Medical Center in Israel, where she practiced for nearly 15 years. This invaluable background in patient care enriches her understanding of the complexities involved in medical advancements.

Vision for the Future

Excited about this new role, Dr. Tweezer-Zaks expressed her enthusiasm by saying, "Joining the executive team is a remarkable opportunity, especially as we prepare for crucial regulatory submissions for our lead product, D-PLEX???, and further develop our promising pipeline, including our new GLP-1 program. The potential to address crucial unmet needs in surgical care, oncology, and metabolic diseases excites me immensely." Her commitment to innovation aligns perfectly with PolyPid's mission to provide groundbreaking solutions in healthcare.

Dr. Tweezer-Zaks holds both an M.D. and a B.S. from Ben-Gurion University School of Medicine and has earned an M.B.A. from the prestigious Kellogg-Recanati International Executive MBA Program, a unique collaboration between Northwestern University and Tel Aviv University.

About PolyPid

PolyPid Ltd. is at the forefront of biopharmaceutical innovation, focusing on enhancing surgical outcomes through locally administered therapeutics. Using their proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology, PolyPid combines active pharmaceutical ingredients for effective drug delivery over varied release periods, ranging from days to months. Following encouraging Phase 3 results for D-PLEX100, which targets abdominal colorectal surgical site infections, the company anticipates submitting a New Drug Application in the near future. Furthermore, PolyPid boasts a robust pipeline with ongoing projects in oncology and diabetes management.

Frequently Asked Questions

Who is the new Chief Medical Officer of PolyPid?

Dr. Nurit Tweezer-Zaks has been appointed as the new Chief Medical Officer of PolyPid Ltd.

What are Dr. Tweezer-Zaks' qualifications?

Dr. Tweezer-Zaks holds M.D. and B.S. degrees from Ben-Gurion University and an M.B.A. from the Kellogg-Recanati International Executive MBA Program.

What is Dr. Tweezer-Zaks' prior experience?

She has served in significant leadership roles, including CEO of MediCane Health Inc. and Chief Medical Officer at aMOON Venture Capital Fund.

What products is PolyPid currently focused on?

PolyPid is focused on D-PLEX100 for preventing surgical site infections and developing a pipeline addressing oncology and metabolic diseases.

What technology does PolyPid utilize?

PolyPid employs its proprietary PLEX technology for delivering therapeutics with controlled and extended-release capabilities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Preplanning Funerals: Choices for Clarity and Comfort

Updated Category News Views 41

Making Clear Plans for the Inevitable Man, if life is certain about one thing, it’s the endgame. And nobody wants to pass the buck on sorting out the details when they’re six feet under. Enter funeral preplanning – a chance to write the script for your own final episode and keep your family out of the weeds when the time comes. Jake Leonetti over at Stone Chapel...

Continue Reading
LIME Faces Investigation Amid Earnings Shortfall

Updated Category News Views 0

Financial Miss Spurs Investigation When you've been in this racket as long as I have, you learn that missing consensus earnings even by a few cents can stir up a financial hornet's nest. That's precisely where Neutron Holdings Inc., better known as Lime, finds itself. With their third-quarter earnings slipping two cents below expectation, at $0.63 against a $0.66 to $0.68...

Continue Reading
Lakefront Living: Steuben County's Twin Tales

Updated Category News Views 43

Here’s how it is: choosing a lakefront home in Steuben County, Indiana, ain't just about picking a place with a killer view. It’s like buying a lifestyle package and you’d better know what you’re getting. An article by Tony Isa, the go-to real estate guru in these parts, puts the spotlight on Lake James and Clear Lake—but what matters is how each might wrangle...

Continue Reading
What Business Owners Need to Know About Glass Replacement

Updated Category News Views 47

Understanding the Nuts and Bolts of Storefront Glass Replacement Picture your storefront beaten and battered, glass cracks spidering over once-pristine panes. Cue Matt Sears of Bentonville Glass Inc. ready to patch things up without turning your business into a disaster zone. The homegrown hero makes his debut in HelloNation's latest chat, offering the kind of advice you...

Continue Reading
West Virginia Water's $850K Upgrade: A Local Boost

Updated Category News Views 127

$850,000 For Aging Pipes: A Long-Needed Move Picture a dusty road in West Virginia—Old Route 38. Now, imagine it bustling with work crews hustling to give the town’s water infrastructure a much-needed facelift. West Virginia American Water is laying down $850,000 to replace 3,500 feet of worn-out pipe with durable PVC, aiming to curb service outages and ensure...

Continue Reading
China's Health-Driven Poverty Approach Offers Global Lessons

Updated Category News Views 39

China's Health Strategy in Poverty Reduction Here's a story that's got global implications tucked into its every corner: China, a country that's been trying to mesh healthcare with poverty reduction, has caught the eye of international observers. This insight was splashed across the latest Lancet Commission report, showcased at Tsinghua University on October 29. It seems...

Continue Reading
Unlikely Collaborators Grants $7.2M to Boost Nonprofits

Updated Category News Views 63

Massive Boost for Nonprofits Across the United States It's not every day you see millions thrown into nonprofit work without some fanfare, right? Unlikely Collaborators just poured a hefty $7.2 million into the coffers of 52 nonprofit outfits scattered across the nation. This spread isn't just about slapping cash on projects—it's about putting Elizabeth R. Koch's...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 96

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Tokenized Stock Trading Takes Flight With SEC Nod

Updated Category News Views 21

Tokenization Breaks New Ground You hear this, folks? We’ve got a whole new chapter kicking off in the stock market here in the U.S., and it's all about tokenized equities. Yeah, that’s right—tokenized stocks are finally getting a nod from the big guns at the SEC. Tradecraft just hit a milestone by facilitating the first-ever tokenized stock transaction under the...

Continue Reading
Menarini & Ryvu's Phase II Results Offer Hope in B-NHL

Updated Category News Views 113

New Glimmers of Hope in B-cell NHL Battle Battling aggressive B-cell non-Hodgkin lymphoma (B-NHL) isn't for the faint of heart, especially when standard treatments have been run through like an old pair of boots. Enter dapolsertib, the fresh-faced newcomer in Menarini Group and Ryvu Therapeutics' arsenal, showing encouraging signals in early Phase II results. These...

Continue Reading

Top 5 Most Recently Viewed Articles

The Honest Company Surges with Impressive Q3 Performance

Updated Category News Views 216

The Honest Company's Successful Third Quarter Results The Honest Company (NASDAQ: HNST), a trailblazer in the personal care sector, recently announced extraordinary results for the third quarter of 2024. With a phenomenal revenue achievement of $99 million, the company demonstrated a remarkable 15% increase compared to the previous year. Significant Financial Highlights...

Continue Reading
Codexis to Highlight Innovations in siRNA Manufacturing at TIDES

Updated Category News Views 135

Codexis Showcases Innovations in siRNA Manufacturing Codexis, Inc. (NASDAQ: CDXS), a leader in enzymatic solutions for scalable therapeutics manufacturing, is preparing to showcase its innovative ECO Synthesis platform at the upcoming TIDES USA annual meeting. This event, which brings together professionals in the field, will take place soon, and Codexis is excited to...

Continue Reading
Abacus Global Management's First Dividend Paves Way for Growth

Updated Category News Views 131

Abacus Global Management Announces Inaugural Dividend Abacus Global Management, Inc., a notable player in the alternative asset management sector, has taken significant steps towards enhancing shareholder value by announcing its first annual cash dividend. This milestone reflects the company's solid performance and intention to sustain a shareholder-focused capital...

Continue Reading
Velcan Holdings Records Significant Challenges in Half-Year Results

Updated Category News Views 162

Velcan Holdings Faces Financial Challenges in Half-Year Report Velcan Holdings has recently released its half-year financial results, highlighting significant shifts in its profitability. The compelling report provides insight into the company's performance amid complex global economic conditions. Understanding Financial Performance Key Financial Figures As of the end of...

Continue Reading
Innovative Alliance Between Context Networks and Play Globally

Updated Category News Views 116

Innovative Alliance Unleashed Today marks a significant step forward in the gaming industry as Context Networks, Inc. and Play Globally announced a transformative strategic stock swap agreement. With this innovative partnership, both companies are poised to reshape the landscape of gamified advertising and enhance player engagement through interactive technologies. This...

Continue Reading